Trial intelligence / Profile preview

Shenfu injection for renal protection during liver transplantation anesthesia management

ChiCTR-TRC-10001166Phase 4Completed

Sponsor
Shanghai Changzheng Hospital
Start
Jan 2011
Countries
1
01

Overview

Phase 4 trial of shenfu injection in acute kidney failure (AKF) (2 arms), sponsored by Shanghai Changzheng Hospital. Primary endpoints: Biochemical indices of renal function, Biochemical indices of inflammatory reaction and 1 more. Started Jan 2011; status: completed.

02

Drugs

shenfu injection
03

Conditions

acute kidney failure (AKF)

Beyond the preview

Go deeper on ChiCTR-TRC-10001166.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-10001166.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call